Skip to main content

Table 3 Correlation between GA and clinicopathological characteristics in 89 young patients with LUAD

From: Molecular features of lung adenocarcinoma in young patients

  ALL GA P EGFR P ERBB2 P ALK P TP53 P
Gender    0.280   0.846   0.922   0.620   1.000
 Males 25 19(76.0%)   5(20.0%)   6(24.0%)   5(20.0%)   2(8.0%)  
 Females 64 41(64.1%)   14(21.9%)   16(25.0%)   10(15.6%)   6(9.4%)  
Differentiation    0.000   0.001   0.000   0.000   0.001
 Well 54 27(50.0%)   5(9.3%)   18(33.3%)   1(1.9%)   2(3.7%)  
 Moderate 13 12(92.3%)   7(53.8%)   4(30.8%)   1(7.7%)   1(7.7%)  
 Poor 22 21(95.5%)   7(31.8%)   0   13(59.1%)   5(22.7%)  
Stage    0.002   0.214   0.103   0.000   0.129
 I-III 74 45(60.8%)   14(18.9%)   21(28.4%)   7(9.5%)   5(6.8%)  
 IV 15 15(100%)   5(33.3%)   1(6.7%)   8(53.3%)   3(20.0%)  
Smoking status    0.261   1.000   0.684   0.173   0.590
 Smokers 9 8(88.9%)   2(22.2%)   3(33.3%)   3(33.3%)   1(11.1%)  
 Never 80 52(65.0%)   17(21.3%)   19(23.8%)   12(15.0%)   7(8.8%)  
\